Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, chordoma, neoplasm	Active, not recruiting	Phase 2	2026-09-04		NCT05041127

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
M.D. Anderson Cancer Center	1145

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
M D Anderson Cancer Center	Houston	United States	667

Clinical trials